Background Neonatal abstinence syndrome (NAS) includes an array of symptoms impacting
opioid-exposed newborns (OEN) owing to postnatal withdrawal from in utero substance …

The increasing use of opioids in pregnant women has led to an alarming rise in the number
of cases of neonates with drug-induced withdrawal symptoms known as neonatal opioid …

Background Neonatal abstinence syndrome (NAS) rates have dramatically increased.
Breastfeeding is a nonpharmacological intervention that may be beneficial, reducing NAS …

Background: Traditional medication-based management of neonatal abstinence syndrome
(NAS) results in long hospitalizations. Nonpharmacologic treatment and using the Eat …

Background The prevalence of substance use, both prescribed and non‐prescribed, is
increasing in many areas of the world. Substance use by women of childbearing age …

Opioid overdose deaths claim 130 Americans lives every day. 1 Although the opioid
epidemic crosses all geographic, demographic, and social lines, this crisis has had a severe …

Background Newborns with prenatal opioid exposure (POE) are commonly diagnosed with
neonatal abstinence/opioid-withdrawal syndromes due to characteristic symptoms and overt …

Introduction Rates of neonatal opioid withdrawal syndrome (NOWS) have paralleled the rise
of opioid use during pregnancy. While short-term phenotypic symptoms of NOWS are well …

Objective Identify factors associated with the need for pharmacologic therapy (PT) among
opioid exposed newborn (OENs). Study design Retrospective analysis of a statewide …

Tens of thousands of infants are impacted yearly by prenatal opioid exposure. The term
neonatal opioid withdrawal syndrome (NOWS) is now replacing the more familiar term …